Are you a supplier IVIg? If so, we would really value your views about future product supply.

Imported IVIg Suppliers Request for Information

In Australia, intravenous immunoglobulin (IVIg) can currently be accessed in two principal ways:

For indications which meet the Criteria for Clinical Use of IVIg, Intragram P (the domestically produced product) and Octagam (an imported product) are available under the National Blood Supply (NBS) arrangements. Under the NBS arrangements the cost of the product is shared between the Commonwealth and the relevant State or Territory.
For indications which do not meet the Criteria for Clinical Use of IVIg, Octagam and Flebogamma (both imported products) are available under the Direct Order arrangements. Under the Direct Order arrangements, the State or Territory Approved Recipient ordering the product bears the full cost of the product.

With the contract for Octagam expiring on 31 December 2010, Australian governments need to make a decision whether to exercise an option under the contract and extend this contract by one year or undertake a new procurement. The NBA is seeking information from suppliers to inform this decision.

The NBA is seeking responses to the Imported IVIg Suppliers Request for Information by Friday, 26 February 2010. We would prefer if your response was in the format of the Request for Information.

Imported IVIg - Suppliers Request For Information February 2010

You can forward your response to the NBA (Attention: Jenny Elgohary) by mail, email or fax:

By mail:

NATIONAL BLOOD AUTHORITY
LOCKED BAG 8430
CANBERRA ACT 2601

By email:

Supply.Management.Plasma@nba.gov.au

By fax:

(02) 6211 8330

Enquiries may be directed by email to Supply.Management.Plasma@nba.gov.au.

Feedback | Privacy | Copyright | Disclaimer | Contact Us